Courses

In this module of a Five-Part Expert Interview Series, Dr. Basil Darras, along with Dr. Robert Graham, will analyze the characteristics of spinal muscular atrophy, as well as discussing the diagnostic criteria. The faculty will discuss how to apply this data into clinical practice in order to improve patient outcomes. Neurologists, pediatricians, primary care physicians, internists, nurse practitioners, nurses, and ...
View Course

In this module of a Five-Part Expert Interview Series, Dr. John Brandsema, along with Dr. Basil Darras, will review the pathology, biology and molecular genetics of spinal muscular atrophy (SMA). This discussion will provide clinicians with a better understanding of the science of spinal muscular atrophy and how it relates to patient care. Neurologists, pediatricians, primary care physicians, internists, nurse ...
View Course

This CME/CNE program will highlight content presented at the Alzheimer’s Association International Conference (AAIC) 2018 held in Chicago, Illinois. The three expert faculty, led by Dr. Richard S. Isaacson, will provide an interactive account of recently released data regarding the treatment and management of patients with Alzheimer’s disease (AD). An overview of Alzheimer’s disease, including disease course, and signs and ...
View Course

This CME/CNE webcast will highlight recent advancements in the prevention and management of stroke. The expert faculty will discuss best practices for assessing risk as well as the modifiable risk factors of stroke. Recent clinical trial data, including that of combination therapy, will be analyzed, as well as strategies for managing the comorbidities that commonly accompany stroke. Best practices for ...
View Course

This CME program is derived from content presented at the 2017 Florida Society of Neurology Annual Meeting. Dr. Augusto Miravalle will review the pathophysiology of multiple sclerosis and how to make more effective treatment plans. Dr. Miravalle will analyze current and emerging clinical trial data for therapeutics in the treatment of multiple sclerosis. Finally, he will discuss how to implement ...
View Course

This CME/CNE program will highlight recent advances in the treatment and management of multiple sclerosis (MS) as presented at the 70^th Annual American Academy of Neurology Meeting held in Los Angeles, California. The four expert faculty, led by Dr. Fred Lublin, will review the pathophysiology of MS as well as the mechanisms of action of current therapies. The role of ...
View Course

This content is derived from a CME symposium held in conjunction with the Advanced Curriculum for Multiple Sclerosis 2018 in San Diego, California. The five expert faculty will highlight individualized therapeutic strategies of switching and sequencing to improve outcomes for patients with multiple sclerosis (MS). Methods for predicating and monitoring disease therapy in the MS patient population will be reviewed ...
View Course

This educational activity will feature content presented at the MS Paris 2017 7th Joint ECTRIMS-ACTRIMS Meeting in Paris, France. Four expert faculty will examine recent prognosis and diagnostic strategies of multiple sclerosis. An analysis of clinical trial data of current and emerging disease modifying therapies as presented at the Joint ACTRIMS-ECTRIMS meeting will be discussed. The faculty will also review ...
View Course

In this module of a Four-Part Expert Interview Series, Dr. Marc E. Agronin, along with Dr. Richard S. Isaacson, course chair, will evaluate available therapeutic options for Alzheimer’s disease (AD) patient. The faculty will highlight the evolution of failed and existing therapies in AD, and their impact on current clinical care, emphasizing strategies for delaying disease progression in the modern ...
View Course

In this module of a Four-Part Expert Interview Series, Dr. James E. Galvin, along with Dr. Richard S. Isaacson, course chair, will relay optimal strategies for early diagnosis of Alzheimer’s disease (AD). Signs and symptoms for the mild, moderate and severe forms of AD will be analyzed, as well as modifiable and non-modifiable risk factors. The faculty will also review ...
View Course